Section Arrow
LNSR.NASDAQ
- LENSAR
Quotes are at least 15-min delayed:2025/06/29 00:21 EDT
Last
 12.76
+0.21 (+1.67%)
Day High 
12.86 
Prev. Close
12.55 
1-M High
13.74 
Volume 
1.33M 
Bid
12.75
Ask
13.44
Day Low
12.4301 
Open
12.6 
1-M Low
11.97 
Market Cap 
149.41M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 12.4 
20-SMA 12.85 
50-SMA 13.48 
52-W High 17.31 
52-W Low 3.5 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-4.86/--
Enterprise Value
151.50M
Balance Sheet
Book Value Per Share
-1.86
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
53.49M
Operating Revenue Per Share
3.21
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
AMIXAutonomix Medical Inc2.01+0.76+60.80%-- 
NAOVNanoVibronix Inc1.17+0.3009+34.62%-- 
BFLYButterfly Network1.96-0.06-2.97%-- 
BBLGBone Biologics Corp4.58+0.42+10.10%0.08PE
BSXBoston Scientific Corp106.53+1.95+1.86%76.05PE
Quotes are at least 15-min delayed:2025/06/29 00:21 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe and Asia.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.